BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biolinerx Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.494 Ladies and gentlemen, thank you for standing by. 00:00:02.494 -- 00:00:04.557 Welcome to the BioLineRx 00:00:04.557 -- 00:00:08.623 second quarter 2025 financial results conference call. 00:00:08.623 -- 00:00:11.967 All participants are present in listen-only mode. 00:00:11.967 -- 00:00:16.093 Song management formal presentation instructions will be given for the question and answer 00:00:16.093 -- 00:00:21.100 session. I would now like to turn over the call to Irina Kossler, 00:00:21.100 -- 00:00:24.704 Investor Relations. Irina, please go ahead. 00:00:24.704 -- 00:00:27.773 Thank you, Operator, and welcome, everyone. 00:00:27.773 -- 00:00:32.142 Thank you for joining us on our quarterly results conference call. 00:00:32.142 -- 00:00:37.533 Earlier today, we issued a press release, a copy of which is available in the investor 00:00:37.533 -- 00:00:43.645 relations section of our website. It was also filed as a 6K. 00:00:43.645 -- 00:00:49.272 I'd like to remind you that certain statements we make during the call will be forward-looking. 00:00:49.272 -- 00:00:55.580 Because such statements deal with future events and are subject to many risks and uncertainties, 00:00:55.580 -- 00:01:00.426 actual results may differ materially from those in the forward-looking statements. 00:01:00.426 -- 00:01:05.653 For a full discussion of these risks and uncertainties, please review our annual 00:01:05.653 -- 00:01:11.400 report on Form 20-X and our quarterly reports on Form 6-K 00:01:11.400 -- 00:01:15.884 that are filed with the U.S. Securities and Exchange Commissions. 00:01:15.884 -- 00:01:19.749 At this time, it is now my pleasure to turn the call over to Mr. 00:01:19.749 -- 00:01:24.532 Phil Sterling, Chief Executive Officer of BioLineRx. 0...